Free Trial
→ $2 Trillion Disappears Because of Fed's Secretive New Move (From Stansberry Research) (Ad) Buy SLNCF Stock  Free SLNCF Stock Alerts

Silence Therapeutics (SLNCF) SEC Filings & 10K Form

Silence Therapeutics logo
$0.97 +0.02 (+2.11%)
As of 05/1/2025 10:55 AM Eastern
Compare

Recent Silence Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/30/2025
6:13 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
5:50 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
8:28 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13D/A
04/24/2025
6:16 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
9:35 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
1:17 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
6:50 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
9:47 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
9:50 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13D/A
03/06/2025
10:03 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:20 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:30 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
9:59 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
7:03 PM		Redmile Group, LLC (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13G
02/11/2025
5:41 PM		Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13G/A
01/02/2025
3:32 PM		HELLUMS RHONDA LYNETTE (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:34 PM		Davidson Michael H. (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:36 PM		Ede-Golightly James (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:38 PM		Ross Iain (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:39 PM		Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
TOOMAN CRAIG A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:43 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics (Issuer)
Silence Therapeutics plc (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
7:00 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:32 PM		Griffiths Richard Ian (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SCHEDULE 13D/A
12/09/2024
7:12 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
3:54 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
8:44 AM		Deep Track Capital, LP (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SC 13G/A
11/14/2024
8:24 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
4:20 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form F-3ASR
08/15/2024
8:05 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2024
5:51 PM		Invus Global Management, LLC (Filed by)
Silence Therapeutics (Subject)
Silence Therapeutics plc (Subject)
Form SC 13G/A
06/27/2024
6:40 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:38 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
7:41 AM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
1:21 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
11:15 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form EFFECT
05/08/2024
4:14 PM		Silence Therapeutics (Filer)
Silence Therapeutics plc (Filer)
Form DEL AM
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (OTCMKTS:SLNCF) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Trump Orders 'National Digital Asset Stockpile'
Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...
Crypto 101 Media | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Gold Alert: The Truth About Fort Knox Is Coming
Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...
Golden Portfolio | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored